| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |